Search
SOLACI Congress
HomeStructural heart diseaseValvular Aortic Valve

Valvular Aortic Valve

View Category
Other

The FDA Approves Sapien 3 with Alterra in Pulmonary Position

The US Food and Drug Administration (FDA) has cleared the SAPIEN 3 valve with the Alterra adaptive pre-stent...
solaci -
Learn More
Institutional News

The Most Relevant of 2021 In Structural Heart Disease

This last year, new data in structural heart disease gave way to changes in practices and new...
solaci -
Learn More
Antithrombotic Anticoagulants

PRAGUE-17: Appendage Closure vs. Direct Anticoagulant Agents

After four years of follow-up, the PRAGUE-17 study showed that appendage closure is non-inferior to direct anticoagulant...
solaci -
Learn More
Structural heart disease

CHOICE-CLOSURE | Which Closure Device for TAVR is Better?

In patients who undergo transcatheter aortic valve replacement (TAVR) through transfemoral access, a closure device based on...
solaci -
Learn More
Structural heart disease

Prosthesis-Annular Size Ratio and Its Impact on Leaks

In low-risk patients, there was a very low incidence of greater than moderate leak, including in patients...
solaci -
Learn More
Structural heart disease

Ten Commandments for 2021 Guidelines on Valvular Heart Disease

Since the latest version to the Valvular Heart Disease Guidelines from the European Society of Cardiology, plenty...
solaci -
Learn More
Structural heart disease

AHA 2021 | AVATAR: Early Intervention in Asymptomatic Aortic Stenosis

Early surgical aortic valve replacement (SAVR) in patients with severe asymptomatic aortic stenosis can be beneficial in...
solaci -
Learn More
Structural heart disease

TAVR vs Sutureless Surgical Aortic Valve Replacement in Low-Risk Patients

Sutureless surgical aortic valve replacement (SU-SAVR) has been designed to make surgical valve replacement easier and faster,...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

PULSE Registry Subanalysis: Radial vs. Femoral Secondary Access

Dr. Omar Tupayachi - 0
In view of its lower complications rate, the transfemoral approach is the most used in transcatheter aortic valve replacement (TAVR), vs. alternative access sites....

Direct Oral Anticoagulants for Ventricular Thrombus After STEMI

Dr. Omar Tupayachi - 0
While the incidence of intracavitary thrombi after acute myocardial infarction (AMI) has decreased thanks to optimized primary angioplasty times, some studies report rates of...

TRILUMINATE: Liver and Kidney Failure in Tricuspid Valve Edge-to-Edge Repair

Dr. Carlos Fava - 0
Severe tricuspid regurgitation (TR) will affect roughly 3% of the 65+ population and may lead to liver and kidney failure, which will cause ascites...

Institutional News

Cuba Sessions 2025 | Young Interventional Cardiologists Contest

solaci - 0
Call for Case Submission L SOLACI Regional Sessions - 18° Central America & The Caribbean Region - It is with great pleasure that we hereby...

Hemodynamics and Interventional Cardioangiology Hybrid Training Course SOLACI-CACI

solaci - 0
We are now open for registration to the hybrid training course on Hemodynamics and Interventional Cardioangiology for Technicians and Nurses SOLACI-CACI 2025 Find all course...

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy